| Product Code: ETC9821473 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Turkey Parkinsons Disease Market Overview |
3.1 Turkey Country Macro Economic Indicators |
3.2 Turkey Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Turkey Parkinsons Disease Market - Industry Life Cycle |
3.4 Turkey Parkinsons Disease Market - Porter's Five Forces |
3.5 Turkey Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Turkey Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 Turkey Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Turkey Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Turkey Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 Turkey Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis rates of Parkinson's disease in Turkey |
4.2.2 Growing elderly population in Turkey, which is a key demographic for Parkinson's disease |
4.2.3 Advancements in medical research leading to improved treatment options for Parkinson's disease in Turkey |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare services in certain regions of Turkey |
4.3.2 High costs associated with Parkinson's disease treatments and medications in Turkey |
5 Turkey Parkinsons Disease Market Trends |
6 Turkey Parkinsons Disease Market, By Types |
6.1 Turkey Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Turkey Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Turkey Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 Turkey Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 Turkey Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 Turkey Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 Turkey Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 Turkey Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 Turkey Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 Turkey Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 Turkey Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 Turkey Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Turkey Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Turkey Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 Turkey Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Turkey Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 Turkey Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Turkey Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Turkey Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Turkey Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Turkey Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 Turkey Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 Turkey Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 Turkey Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Turkey Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Turkey Parkinsons Disease Market Import-Export Trade Statistics |
7.1 Turkey Parkinsons Disease Market Export to Major Countries |
7.2 Turkey Parkinsons Disease Market Imports from Major Countries |
8 Turkey Parkinsons Disease Market Key Performance Indicators |
8.1 Number of neurologists specializing in movement disorders in Turkey |
8.2 Percentage of Parkinson's disease patients receiving timely and appropriate treatment in Turkey |
8.3 Research and development investment in Parkinson's disease therapies in Turkey |
9 Turkey Parkinsons Disease Market - Opportunity Assessment |
9.1 Turkey Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Turkey Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 Turkey Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Turkey Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Turkey Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 Turkey Parkinsons Disease Market - Competitive Landscape |
10.1 Turkey Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 Turkey Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here